We are live on ! Find out more
RXRX icon

Recursion Pharmaceuticals
RXRX

133 hedge funds and large institutions have $861M invested in Recursion Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 45 increasing their positions, 33 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 21

36% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 33

33% more funds holding in top 10

Funds holding in top 10: 6 → 8 (+2)

27% more capital invested

Capital invested by funds: $680M → $861M (+$181M)

6.23% more ownership

Funds ownership: 58.75% → 64.98% (+6.2%)

4% more funds holding

Funds holding: 128 → 133 (+5)

15% less call options, than puts

Call options by funds: $499K | Put options by funds: $588K

Holders
133
Holders Change
+5
Holders Change %
+3.91%
% of All Funds
2.24%
Holding in Top 10
8
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+33.33%
% of All Funds
0.13%
New
29
Increased
45
Reduced
33
Closed
21
Calls
$499K
Puts
$588K
Net Calls
-$89K
Net Calls Change
-$132K

Top Buyers

Rank Fund Capital Flow
1
MCMU
MIC Capital Management (UK)
United Kingdom
+$47.3M
2
Norges Bank
Norges Bank
Norway
+$19.1M
3
BlackRock
BlackRock
New York
+$10.3M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$4.62M
5
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group
Japan
+$2.68M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$4.03M
2
CC
Casdin Capital
New York
-$3.92M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$3.61M
4
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
-$2.52M
5
American Century Companies
American Century Companies
Missouri
-$2.16M
Name Holding Trade Value Shares
Change 		Change in
Stake
Royal Bank of Canada
126
Royal Bank of Canada
Ontario, Canada
$8K -$40.6K -6,069 -86%
CG
127
Cutler Group
California
$8K -$937 -140 -12%
DFCM
128
Dark Forest Capital Management
Puerto Rico
$7K +$5.63K +841 New
AWM
129
Activest Wealth Management
Florida
$2K – – –
NMG
130
New Millennium Group
Utah
$2K +$1.84K +275 New
AFG
131
Albion Financial Group
Utah
$1K – – –
CC
132
Casdin Capital
New York
– -$3.92M -548,156 Closed
American Century Companies
133
American Century Companies
Missouri
– -$2.16M -301,984 Closed
Two Sigma Investments
134
Two Sigma Investments
New York
– -$1.43M -200,131 Closed
TC
135
TwinBeech Capital
New York
– -$1.25M -174,923 Closed
PCM
136
Pinz Capital Management
New York
– -$1.02M -142,168 Closed
EGM
137
Engineers Gate Manager
New York
– -$588K -82,120 Closed
Squarepoint
138
Squarepoint
New York
– -$403K -56,332 Closed
HF
139
HRT Financial
New York
– -$380K -53,204 Closed
Two Sigma Advisers
140
Two Sigma Advisers
New York
– -$287K -40,100 Closed
TD Asset Management
141
TD Asset Management
Ontario, Canada
– -$233K -32,534 Closed
Walleye Capital
142
Walleye Capital
New York
– -$221K -30,882 Closed
BCM
143
Bayesian Capital Management
New York
– -$184K -25,700 Closed
Mitsubishi UFJ Asset Management
144
Mitsubishi UFJ Asset Management
Japan
– -$117K -16,347 Closed
Tudor Investment Corp
145
Tudor Investment Corp
Connecticut
– -$85K -11,914 Closed
Assenagon Asset Management
146
Assenagon Asset Management
Luxembourg
– -$73K -10,179 Closed
TWA
147
TCI Wealth Advisors
Arizona
– -$4K -594 Closed
Simplex Trading
148
Simplex Trading
Illinois
– -$2.66K -397 Closed
PCG
149
Private Capital Group
Connecticut
– -$1K -196 Closed
CAPTRUST Financial Advisors
150
CAPTRUST Financial Advisors
North Carolina
– -$1K -161 Closed
3 4 5
6
7

RXRX Hedge Fund Activity: Q2 2022 in Review

133 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Recursion Pharmaceuticals (RXRX) for Q2 2022, worth a combined $861M — up 27% from $680M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new RXRX positions and 21 closed out — a net gain of 8 holders — while 45 added to existing stakes and 33 trimmed.

The largest buyer was MIC Capital Management (UK), adding an estimated $47.3M. The largest seller was Citadel Advisors, cutting an estimated $4.03M.

  • 133 institutional investors held Recursion Pharmaceuticals (RXRX) as of Q2 2022, up from 128 in Q1 2022.
  • Funds reported $861M of Recursion Pharmaceuticals stock for Q2 2022, up 27% quarter-over-quarter.
  • 29 funds opened new Recursion Pharmaceuticals positions in Q2 2022 and 21 closed out, a net change of +8 holders.
  • The largest Recursion Pharmaceuticals buyer in Q2 2022 was MIC Capital Management (UK), an estimated $47.3M added.
  • The largest Recursion Pharmaceuticals seller in Q2 2022 was Citadel Advisors, an estimated $4.03M sold.

Based on aggregated 13F filings for Q2 2022.